Immunogen, inc. (IMGN)
CashFlow / TTM
Mar'20Dec'19Sep'19Jun'19Mar'19Dec'18Sep'18Jun'18Mar'18Dec'17Sep'17Jun'17Mar'17Dec'16Sep'16Jun'16Mar'16Dec'15Sep'15Jun'15Mar'15Dec'14Sep'14Jun'14Mar'14Dec'13Sep'13Jun'13Mar'13Dec'12Sep'12Jun'12Mar'12Dec'11Sep'11Jun'11Mar'11Dec'10Sep'10
Cash flows from operating activities:
Net loss

-89,449

-104,100

-150,699

-175,806

-173,981

-168,843

-140,162

-150,037

-117,280

-96,012

-117,046

-105,095

-142,150

-156,733

-155,808

-144,817

-129,369

-119,059

-72,197

-60,739

-56,764

-72,597

-82,420

-71,364

-66,740

-30,640

-58,845

-72,811

-73,350

-90,668

-79,028

-73,319

-67,055

-63,389

-64,869

-58,274

0

0

0

Adjustments to reconcile net loss to net cash (used for) provided by operating activities:
Non-cash royalty revenue related to sale of future royalties

51,924

47,415

41,383

36,622

33,452

32,154

30,460

28,522

27,719

28,142

27,265

26,946

26,451

26,218

25,799

25,299

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Non-cash interest expense on liability related to sale of future royalties and convertible senior notes

19,149

16,879

13,953

12,224

11,017

10,631

11,424

12,263

13,153

13,682

14,108

15,741

17,196

18,593

20,005

20,130

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Depreciation and amortization

3,329

4,000

4,485

4,782

6,073

7,400

7,885

8,122

7,021

6,000

5,853

6,008

6,085

6,014

5,728

5,327

5,104

5,082

5,251

5,513

5,401

5,109

4,825

4,598

4,560

4,612

4,629

4,641

4,679

4,652

4,644

4,633

4,744

4,878

4,922

4,937

0

0

0

(Gain) loss on sale/disposal of fixed assets and impairment charges

-536

-1,689

-2,689

-2,549

-589

-115

-29

-29

-29

-239

-340

-1,310

-1,318

-1,135

-955

21

0

0

0

-

-

-

-

-20

-21

-16

-16

21

-52

-57

-39

-51

17

16

-2

-9

0

0

0

Gain on sale of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

341

0

0

0

Amortization of deferred lease incentive obligation

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

0

-

0

0

0

Gain on forward contracts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

2

49

36

201

197

24

46

-131

-173

-55

-21

-1

189

0

0

0

Impairment charge related to restructuring

-

-

-

-

-

-

-

-

-

-

-

-

-

-

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Stock and deferred share unit compensation

12,182

14,167

15,464

16,248

18,067

16,807

15,149

13,396

12,507

11,325

12,298

14,138

15,581

20,199

20,961

22,247

20,579

16,998

16,088

15,715

16,489

16,634

16,695

16,080

15,307

14,451

13,626

12,751

12,232

11,579

11,604

10,252

9,369

8,239

6,868

5,778

0

0

0

Deferred rent

-

-

-

-

-

95

42

17

-81

-91

-96

-137

-176

-193

-195

-161

-132

-124

-132

-195

-366

-461

-395

-297

-64

92

88

109

109

109

109

109

127

80

39

4

0

0

0

Change in operating assets and liabilities:
Accounts receivable

-179

5,799

-2,021

-19

199

-948

-406

-1,005

-3,859

623

2,205

141

3,789

1,223

-6,496

-4,205

-650

-2,306

4,974

3,192

718

-709

-3,951

1,896

-5,410

2,532

4,936

-129

4,016

-19,928

852

-4,539

-841

20,140

-1,906

2,873

0

0

0

Unbilled revenue/reimbursement

-2,229

384

2,488

1,952

1,144

-1,963

-2,079

-1,285

787

-4,198

1,140

398

1,024

5,893

561

695

491

307

115

-615

-1,451

-1,326

-1,195

-792

-118

-102

533

925

821

1,031

348

-292

-1,232

-1,381

-643

-107

0

0

0

Inventory

-

-

-

-

-

-1,038

-305

-1,592

-2,857

-1,154

216

2,575

2,317

655

781

-2,028

-1,794

-382

-869

-15

218

-1,089

444

2,247

2,372

2,558

1,501

-585

-819

-656

-977

808

204

-526

-353

-762

0

0

0

Contract asset

990

3,131

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Prepaid and other current assets

943

963

-1,359

-3,244

1,030

1,495

1,575

5,135

-714

-2,419

-2,736

-123

-941

-1,232

3,401

706

4,548

4,465

2,285

1,855

-717

-478

-1,655

-571

1,571

401

729

181

-966

325

1,132

-253

-117

238

177

1,038

0

0

0

Operating lease right-of-use assets

1,336

1,331

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Restricted cash

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-1,018

-1,019

-1,019

-1,019

-574

0

0

0

Other assets

3,166

75

-528

-2,587

-1,016

-88

828

1,289

1,488

777

-20

-277

272

82

2,225

2,455

2,882

2,893

804

761

-287

-351

-95

-4

0

0

0

-

-

-

-

16

44

-48

-21

-38

0

0

0

Accounts payable

1,004

-1,045

-2,504

-4,403

726

2,667

3,184

7,036

2,557

771

-2,120

-5,641

-3,937

-3,772

-1,022

2,649

2,612

5,699

4,732

3,319

1,579

1,801

1,835

321

2,020

-894

-94

1,103

88

3,222

366

182

66

-285

1,758

149

0

0

0

Accrued compensation

1,917

-2,189

3,816

12,510

-1,248

323

1,791

1,312

744

4,527

1,779

-3,512

-1,662

1,491

3,484

2,378

-582

776

-450

1,481

775

517

436

712

1,333

989

840

1,211

950

387

130

219

245

325

469

522

0

0

0

Other accrued liabilities

-1,824

-6,146

-10,117

-3,403

-677

3,839

9,492

5,469

9,047

4,375

3,703

1,762

2,145

2,860

-525

-1,434

765

-794

2,348

3,248

329

990

-803

-394

-691

308

-1,732

481

692

-6

2,879

133

-650

-700

-234

-375

0

0

0

Deferred revenue

-18,500

46,630

63,547

64,160

67,918

-9,165

-33,410

41,857

62,476

61,540

88,109

12,234

-11,548

31

-8,856

-8,318

-9,543

11,502

-16,708

-20,155

-19,272

-40,065

-12,315

-16,675

-16,980

-22,659

-13,610

-7,232

-8,102

-2,011

16,441

18,219

18,361

17,993

43,085

42,229

0

0

0

Operating lease liability

-2,651

-2,505

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Proceeds from landlord for tenant improvements

-

-

-

-

-

-

-

-

-

-

-

-

-

0

0

-

-

-

-

-1,350

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash (used for) provided by operating activities

-126,885

-88,367

-97,095

-101,951

-106,264

-166,422

-154,546

-68,756

-9,351

7,645

1,242

-92,536

-149,522

-142,642

-140,969

-124,476

-120,022

-86,398

-67,743

-55,291

-45,759

-66,404

-48,974

-53,650

-46,341

-39,219

-62,868

-60,299

-64,860

-52,963

-43,729

-34,288

-32,047

-50,418

-4,271

-7,989

0

0

0

Proceeds from maturities or sales of marketable securities

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

1,201

0

0

0

Purchases of property and equipment

739

2,845

3,788

5,474

6,345

5,246

4,489

2,464

1,707

1,116

1,071

2,185

3,613

6,655

8,181

10,376

11,525

9,962

9,094

7,425

7,979

8,477

9,320

8,184

6,066

4,029

3,376

3,770

3,541

4,112

3,320

2,908

2,279

1,986

2,235

2,029

0

0

0

Proceeds from sale of equipment

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net cash provided by (used for) investing activities

2,999

-533

-3,788

-5,474

-6,345

-5,246

-4,489

-2,464

-1,707

-1,116

-1,071

-2,185

-3,613

-6,655

-8,181

-10,376

-11,003

-9,962

-9,094

-7,425

-8,501

-8,477

-9,321

-8,185

-6,051

-3,944

-3,256

-3,696

-3,487

-4,128

-3,388

-2,968

-2,299

-2,013

-2,201

-660

0

0

0

Cash flows from financing activities:
Payments from settlement of forward contracts

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-74

-54

16

68

60

20

27

-34

-168

0

0

0

Proceeds from issuance of common stock under stock plans

3,045

2,873

2,169

2,220

2,110

4,301

0

0

0

-

-

-

-

-

699

5,161

7,976

7,904

8,747

4,429

2,011

3,397

5,255

9,136

10,365

10,230

7,363

4,026

5,199

5,749

6,960

6,988

5,813

4,337

3,315

2,719

0

0

0

Proceeds from common stock issuance, net of $229 of transaction costs

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

93,991

0

0

0

-

-

-

-

-

-

-

-

Net cash provided by financing activities

100,789

2,873

2,169

2,192

164,622

166,813

0

0

0

-

-

-

-

-

97,307

101,769

202,111

202,039

202,882

198,564

2,011

3,397

5,255

9,136

10,365

10,230

7,348

98,017

99,190

99,740

100,966

6,988

93,793

92,317

91,295

90,699

0

0

0

Net change in cash and cash equivalents

-23,097

-86,027

0

0

0

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

-

Net change in cash and cash equivalents

-

-

-

-

-

-

-

-

91,815

-

-1,149

-94,689

-56,345

-52,319

-51,843

-33,083

71,086

105,679

126,045

135,848

-52,249

-71,484

-53,040

-52,699

-42,027

-32,933

-58,776

34,022

30,843

42,649

53,849

-30,268

59,447

39,886

84,823

82,050

0

0

0